학술논문
Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk
Document Type
Article
Author
Richard, S.; Chari, A.; Jagannath, S.; Delimpasi, S.; Simonova, M.; Spicka, I.; Pour, L.; Kriachok, I.; Dimopoulos, M.A.; Pylypenko, H.; Auner, H.W.; Leleu, X.; Usenko, G.; Hajek, R.; Benjamin, R.; Dolai, T.K.; Sinha, D.K.; Venner, C.P.; Garg, M.; Stevens, D.A.; Quach, H.; Moreau, P.; Levy, M.; Badros, A.; Anderson, L.D.; Bahlis, N.J.; Facon, T.; Mateos, M.V.; Cavo, M.; Chang, H.; Landesman, Y.; Chai, Y.; Arazy, M.; Shah, J.; Shacham, S.; Kauffman, M.G.; Grosicki, S.; Richardson, P.G.
Source
In: American Journal of Hematology . (American Journal of Hematology, 1 September 2021, 96(9):1120-1130)
Subject
Language
English
ISSN
10968652
03618609
03618609